文献速递胃肠动力与功能性疾病

感染性肠炎后肠易激综合征长期风险与医疗负担队列研究

Cohort Study: Long-Term Risk and Healthcare Burden of Irritable Bowel Syndrome Following Infection Enteritis in 202,244 Patients.
PubMed 文献 · Aliment Pharmacol Ther · 2026-03-13

基于TriNetX美国网络回顾性队列,感染性肠炎成人匹配对照各202,244例。1年时感染性肠炎组IBS风险RR=2.35(95%CI 2.14-2.59)、功能性消化不良RR=2.02(95%CI 1.84-2.22),相关用药、腹部影像和内镜检查率均升高,5年和10年风险仍显著升高。

要点

  • 感染性肠炎后1年IBS风险为对照2.35倍,功能性消化不良2.02倍。
  • 感染性肠炎组相关用药、腹部影像及内镜检查率均显著高于对照。
  • 沙门菌/志贺菌(RR=6.48)和蓝氏贾第鞭毛虫(RR=5.05)后IBS风险最高。

核心结论

  • 感染性肠炎与IBS和功能性消化不良风险升高、相关用药增加及医疗资源利用增多相关。

研究设计与样本

  • 回顾性队列研究,使用TriNetX美国网络,感染性肠炎成人匹配对照,匹配后每组202,244例。

主要发现

  • 随访1年,感染性肠炎组IBS风险RR=2.35(95%CI 2.14-2.59),功能性消化不良RR=2.02(95%CI 1.84-2.22)。
  • 随访1年,IBS相关用药RR=1.29(95%CI 1.26-1.31),功能性消化不良相关用药RR=1.56(95%CI 1.55-1.59)。
  • 随访1年,腹部影像RR=2.42(95%CI 2.29-2.54),食管胃十二指肠镜/结肠镜RR=1.57(95%CI 1.50-1.65)。
  • 上述风险在5年和10年随访时仍显著高于对照。
  • 沙门菌/志贺菌(RR=6.48)和蓝氏贾第鞭毛虫(RR=5.05)后发生IBS风险最高。

临床怎么用

  • 对感染性肠炎后患者,尤其沙门菌/志贺菌或蓝氏贾第鞭毛虫感染者,应关注IBS和功能性消化不良症状长期随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infection enteritis is associated with the development of irritable bowel syndrome (IBS) and functional dyspepsia. AIM: This study aimed to examine the long-term risk of IBS and functional dyspepsia, and associated health care utilisation following infection enteritis. METHODS: We conducted a retrospective cohort study using TriNetX U.S. Network. Adults with infection enteritis were identified and matched to controls, balancing demographics and comorbidities. Primary outcomes were the risk of incident IBS and functional dyspepsia diagnoses at 1, 5, and 10 years. Secondary outcomes were rates of IBS- and functional dyspepsia-related medications, endoscopy, abdominal imaging, and hospitalizations. Pathogen-specific and multivariate analyses were performed to assess variations in IBS risk. RESULTS: After matching, 202,244 patients were identified in each study cohort. At 1 year of follow-up, the infection enteritis cohort had higher rates of IBS (RR = 2.35; 95% CI: 2.14-2.59), functional dyspepsia (RR = 2.02; 95% CI: 1.84-2.22), use of IBS-related medications (RR = 1.29; 95% CI: 1.26-1.31), functional dyspepsia-related medications (RR = 1.56; 95% CI: 1.55-1.59), abdominal imaging (RR = 2.42; 95% CI: 2.29-2.54), and Oesophagogastroduodenoscopy/colonoscopy (RR = 1.57; 95% CI: 1.50-1.65). These risks remained significantly higher in the IE cohort at 5 and 10 years. Salmonella/Shigella (RR = 6.48), and Giardia lamblia (RR = 5.05) had the highest risk of developing incident IBS. CONCLUSION: Infection enteritis was associated with increased risk of IBS and functional dyspepsia, rates of related medication use, and greater healthcare utilisation.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Eldesouki MH, Kloub M, Elfert K, et al. Cohort Study: Long-Term Risk and Healthcare Burden of Irritable Bowel Syndrome Following Infection Enteritis in 202,244 Patients. Aliment Pharmacol Ther. 2026. PMID: 41826274. doi:10.1111/apt.70602

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。